To help affected parents, RSV medication should be cheaper and easier to access

Nur Suhana and Roslan with their son Shafiq Rizqi, whose lung conditions improved following monoclonal antibody treatment. — Photos: ART CHEN/The Star

SHAFIQ Rizqi Ruslan, 21 months, doesn’t need a microphone to have his voice fill the small conference room in Bangsar South. Oblivious of his surroundings, his high-pitched voice and giggles manage to overshadow the voice of invited speakers at a media roundtable to discuss respiratory syncytial virus (RSV), a condition he contracted as a baby.

He turns one corner of the room into his small playpen but only for a while, before he starts running, playing catch-me-if-you-can with his father Ruslan Mukhtar, 41, who playfully chases the toddler out of the room.